Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve

<div>Representative images of embryos of different grades. <i>Note.</i> Grade 1 embryo: blastomeres of equal size, regular morphology, bright, and no fragments. Grade 2 embryo: blastomeres of unequal size and/or fragmentation &lt;10%. Grade 3 embryo: 10–50% fragmentation. Grade 4 embryo: fragmentation &gt;50%.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve 

Figure 2 | Proteomic Analysis of Human Follicular Fluid Reveals the Pharmacological Mechanisms of the Chinese Patent Drug Kunling Pill for Improving Diminished Ovarian Reserve 